Literature DB >> 15738775

Validation of the Korean version of the oswestry disability index.

Dong-Yun Kim1, Sang-Ho Lee, Ho-Yeon Lee, Hyun-Ju Lee, Sang-Beom Chang, Sang-Ki Chung, Hyun-Jib Kim.   

Abstract

STUDY
DESIGN: Validation of a translated, culturally adapted questionnaire.
OBJECTIVES: To translate and culturally adapt a Korean version of the Oswestry Disability Index (ODI) and to validate its use in Korean patients. SUMMARY OF BACKGROUND DATA: The ODI is one of the most widely used and validated instruments for measuring disability in spinal disorders. However, no validated Korean version of the index was available at the time our study was initiated.
METHODS: The study was carried out in three phases: the first was translation into Korean and cultural adaptation of the questionnaire; the second was a pilot study to assess the comprehensibility of the prefinal version and modification; the third was a reliability and validity study of the final version. The Korean version was tested on 206 patients with lumbar spinal disorders who had undergone operations at the authors' institute. Test-retest reliability, internal consistency, concurrent validity, and construct validity were investigated. Follow-up questionnaires were obtained from 39 patients at the 3-month postoperative follow-up meeting. Differences in the ODI, visual analog scale (VAS), and World Health Organization (WHO) quality of life assessment (WHOQOL-BREF) between preoperative and follow-up questionnaires were evaluated. The correlation of the postoperative ODI with the pain rating on a visual analog scale and WHOQOL-BREF was also analyzed.
RESULTS: Test-retest reliability was assessed with 88 patients in a time interval of 48 hours. The intraclass correlation coefficient of test-retest reliability was 0.9167. Reliability estimated by the internal consistency reached a Cronbach's alpha of 0.84. The correlation of the preoperative ODI with the pain rating on a visual analog scale (100 mm) was r = 0.425 (P = 0.0001). The correlation between three of the WHOQOL-BREF domains (physical health, psychological health, and environment) and the ODI was statistically significant. The correlation coefficient between the ODI and physical health domain of the WHOQOL-BREF was r = -0.48 (P < 0.05). The correlations with psychological health and environment domains were low with r = -0.192 and -0.160, respectively, even though statistically significant (P < 0.05). The correlation of the postoperative ODI with the pain rating on a visual analog scale (100 mm) was r = 0.626 (P = 0.0001). The correlation between all four domains of the WHOQOL-BREF and the postoperative ODI was statistically significant.
CONCLUSIONS: The results of this study indicate that the Korean version of the ODI is a reliable and valid instrument for the measurement of disability in Korean patients with lower back problems. The authors recommend this Korean version of the ODI for use in future clinical studies in Korea.

Entities:  

Mesh:

Year:  2005        PMID: 15738775     DOI: 10.1097/01.brs.0000157172.00635.3a

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  49 in total

1.  Discriminative validity and responsiveness of the Oswestry Disability Index among Japanese outpatients with lumbar conditions.

Authors:  Hideki Hashimoto; Masahi Komagata; Osamu Nakai; Masutaro Morishita; Yasuaki Tokuhashi; Shigeo Sano; Yutaka Nohara; Yukikazu Okajima
Journal:  Eur Spine J       Date:  2006-02-14       Impact factor: 3.134

2.  Individual characteristics of reliable lumbar coupling motions.

Authors:  Woo-Suck Yun; Hyunho Kim; Ji Hoon Ahn; Young-Bae Park; Young-Jae Park
Journal:  Eur Spine J       Date:  2015-06-24       Impact factor: 3.134

3.  Laser-assisted endoscopic lumbar foraminotomy for failed back surgery syndrome in elderly patients.

Authors:  Yong Ahn; Han Joong Keum; Sang Ha Shin; Jung Ju Choi
Journal:  Lasers Med Sci       Date:  2019-05-17       Impact factor: 3.161

4.  Validation of the Croatian version of the Oswestry Disability Index.

Authors:  Ivan Domazet; Jakob Nemir; Petra Barl; Krešimir Saša Đurić; Ivan Pašalić; Hrvoje Barić; Marin Stančić
Journal:  Eur Spine J       Date:  2018-09-08       Impact factor: 3.134

5.  The dischargeable cut-off score of Oswestry Disability Index (ODI) in the inpatient care for low back pain with disability.

Authors:  Sang-Won Park; Ye-Sle Shin; Hye-Jin Kim; Jin-Ho Lee; Joon-Shik Shin; In-Hyuk Ha
Journal:  Eur Spine J       Date:  2014-08-07       Impact factor: 3.134

6.  A mid-term follow-up result of spinopelvic fixation using iliac screws for lumbosacral fusion.

Authors:  Seung-Jae Hyun; Seung-Chul Rhim; Yongjung J Kim; Young-Bae Kim
Journal:  J Korean Neurosurg Soc       Date:  2010-10-30

7.  Psychometric characteristics of the Korean version of the Roland-Morris Disability Questionnaire.

Authors:  Jeeyoun Moon; Yong Chul Kim; Soo Young Park; Sang Chul Lee; Seung Pyo Choi; Francis Sahngun Nahm; Pyung Bok Lee; Eui Kyung Goo; Jong-Man Kang
Journal:  J Korean Med Sci       Date:  2011-10-01       Impact factor: 2.153

8.  Reliability and validity study on the Hungarian versions of the oswestry disability index and the Quebec back pain disability scale.

Authors:  Tamás Valasek; Peter Paul Varga; Zsolt Szövérfi; Michelle Kümin; Jeremy Fairbank; Aron Lazary
Journal:  Eur Spine J       Date:  2013-01-16       Impact factor: 3.134

9.  Clinical and radiological comparison of unipedicular versus bipedicular balloon kyphoplasty for the treatment of vertebral compression fractures.

Authors:  B-K Song; J-P Eun; Y-M Oh
Journal:  Osteoporos Int       Date:  2009-03-04       Impact factor: 4.507

10.  Validation and cross-cultural adaptation of the Korean version of the Core Outcome Measures Index in patients with degenerative lumbar disease.

Authors:  Ho-Joong Kim; Jin S Yeom; Yunjin Nam; Na-Kyoung Lee; Young Woo Heo; Se Yeon Lee; Jiwon Park; Bong-Soon Chang; Choon-Ki Lee; Heoung-Jae Chun; Anne F Mannion
Journal:  Eur Spine J       Date:  2018-09-17       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.